 | • レポートコード：MRC2-11QY14599 • 出版社/出版日：QYResearch / 2020年11月30日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、111ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は放射線障害治療薬のグローバル市場について調査・分析したレポートです。種類別（Aerosurf、BMX-001、C-2E2、C-2E5、Des-Aspアンジオテンシン1、DG-3、その他）市場規模、用途別（ASC、病院、クリニック、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別放射線障害治療薬の競争状況、市場シェア ・世界の放射線障害治療薬市場：種類別市場規模 2015年-2020年（Aerosurf、BMX-001、C-2E2、C-2E5、Des-Aspアンジオテンシン1、DG-3、その他） ・世界の放射線障害治療薬市場：種類別市場規模予測 2021年-2026年（Aerosurf、BMX-001、C-2E2、C-2E5、Des-Aspアンジオテンシン1、DG-3、その他） ・世界の放射線障害治療薬市場：用途別市場規模 2015年-2020年（ASC、病院、クリニック、その他） ・世界の放射線障害治療薬市場：用途別市場規模予測 2021年-2026年（ASC、病院、クリニック、その他） ・北米の放射線障害治療薬市場分析：米国、カナダ ・ヨーロッパの放射線障害治療薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの放射線障害治療薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の放射線障害治療薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの放射線障害治療薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：FirstString Research Inc、PharmaIN Corp、Synedgen Inc、Tonix Pharmaceuticals Holding Corp、Windtree Therapeutics Inc ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Radiation Injury Drugs Market
The global Radiation Injury Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Radiation Injury Drugs Scope and Market Size
Radiation Injury Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Radiation Injury Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Radiation Injury Drugs market is segmented into
Aerosurf
BMX-001
C-2E2
C-2E5
Des-Asp Angiotensin 1
DG-3
Others
Segment by Application, the Radiation Injury Drugs market is segmented into
ASCs
Hospital
Clinic
Others
Regional and Country-level Analysis
The Radiation Injury Drugs market is analysed and market size information is provided by regions (countries).
The key regions covered in the Radiation Injury Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Radiation Injury Drugs Market Share Analysis
Radiation Injury Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Radiation Injury Drugs business, the date to enter into the Radiation Injury Drugs market, Radiation Injury Drugs product introduction, recent developments, etc.
The major vendors covered:
FirstString Research Inc
PharmaIN Corp
Synedgen Inc
Tonix Pharmaceuticals Holding Corp
Windtree Therapeutics Inc
…
1 Study Coverage
1.1 Radiation Injury Drugs Product Introduction
1.2 Market Segments
1.3 Key Radiation Injury Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Radiation Injury Drugs Market Size Growth Rate by Type
1.4.2 Aerosurf
1.4.3 BMX-001
1.4.4 C-2E2
1.4.5 C-2E5
1.4.6 Des-Asp Angiotensin 1
1.4.7 DG-3
1.4.8 Others
1.5 Market by Application
1.5.1 Global Radiation Injury Drugs Market Size Growth Rate by Application
1.5.2 ASCs
1.5.3 Hospital
1.5.4 Clinic
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Radiation Injury Drugs Market Size, Estimates and Forecasts
2.1.1 Global Radiation Injury Drugs Revenue 2015-2026
2.1.2 Global Radiation Injury Drugs Sales 2015-2026
2.2 Global Radiation Injury Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Radiation Injury Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Radiation Injury Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Radiation Injury Drugs Competitor Landscape by Players
3.1 Radiation Injury Drugs Sales by Manufacturers
3.1.1 Radiation Injury Drugs Sales by Manufacturers (2015-2020)
3.1.2 Radiation Injury Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 Radiation Injury Drugs Revenue by Manufacturers
3.2.1 Radiation Injury Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Radiation Injury Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Radiation Injury Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Radiation Injury Drugs Revenue in 2019
3.2.5 Global Radiation Injury Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Radiation Injury Drugs Price by Manufacturers
3.4 Radiation Injury Drugs Manufacturing Base Distribution, Product Types
3.4.1 Radiation Injury Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Radiation Injury Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Radiation Injury Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Radiation Injury Drugs Market Size by Type (2015-2020)
4.1.1 Global Radiation Injury Drugs Sales by Type (2015-2020)
4.1.2 Global Radiation Injury Drugs Revenue by Type (2015-2020)
4.1.3 Radiation Injury Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Radiation Injury Drugs Market Size Forecast by Type (2021-2026)
4.2.1 Global Radiation Injury Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Radiation Injury Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Radiation Injury Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Radiation Injury Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Radiation Injury Drugs Market Size by Application (2015-2020)
5.1.1 Global Radiation Injury Drugs Sales by Application (2015-2020)
5.1.2 Global Radiation Injury Drugs Revenue by Application (2015-2020)
5.1.3 Radiation Injury Drugs Price by Application (2015-2020)
5.2 Radiation Injury Drugs Market Size Forecast by Application (2021-2026)
5.2.1 Global Radiation Injury Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Radiation Injury Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Radiation Injury Drugs Price Forecast by Application (2021-2026)
6 North America
6.1 North America Radiation Injury Drugs by Country
6.1.1 North America Radiation Injury Drugs Sales by Country
6.1.2 North America Radiation Injury Drugs Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Radiation Injury Drugs Market Facts & Figures by Type
6.3 North America Radiation Injury Drugs Market Facts & Figures by Application
7 Europe
7.1 Europe Radiation Injury Drugs by Country
7.1.1 Europe Radiation Injury Drugs Sales by Country
7.1.2 Europe Radiation Injury Drugs Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Radiation Injury Drugs Market Facts & Figures by Type
7.3 Europe Radiation Injury Drugs Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Radiation Injury Drugs by Region
8.1.1 Asia Pacific Radiation Injury Drugs Sales by Region
8.1.2 Asia Pacific Radiation Injury Drugs Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Radiation Injury Drugs Market Facts & Figures by Type
8.3 Asia Pacific Radiation Injury Drugs Market Facts & Figures by Application
9 Latin America
9.1 Latin America Radiation Injury Drugs by Country
9.1.1 Latin America Radiation Injury Drugs Sales by Country
9.1.2 Latin America Radiation Injury Drugs Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Radiation Injury Drugs Market Facts & Figures by Type
9.3 Central & South America Radiation Injury Drugs Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Radiation Injury Drugs by Country
10.1.1 Middle East and Africa Radiation Injury Drugs Sales by Country
10.1.2 Middle East and Africa Radiation Injury Drugs Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Radiation Injury Drugs Market Facts & Figures by Type
10.3 Middle East and Africa Radiation Injury Drugs Market Facts & Figures by Application
11 Company Profiles
11.1 FirstString Research Inc
11.1.1 FirstString Research Inc Corporation Information
11.1.2 FirstString Research Inc Description and Business Overview
11.1.3 FirstString Research Inc Sales, Revenue and Gross Margin (2015-2020)
11.1.4 FirstString Research Inc Radiation Injury Drugs Products Offered
11.1.5 FirstString Research Inc Related Developments
11.2 PharmaIN Corp
11.2.1 PharmaIN Corp Corporation Information
11.2.2 PharmaIN Corp Description and Business Overview
11.2.3 PharmaIN Corp Sales, Revenue and Gross Margin (2015-2020)
11.2.4 PharmaIN Corp Radiation Injury Drugs Products Offered
11.2.5 PharmaIN Corp Related Developments
11.3 Synedgen Inc
11.3.1 Synedgen Inc Corporation Information
11.3.2 Synedgen Inc Description and Business Overview
11.3.3 Synedgen Inc Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Synedgen Inc Radiation Injury Drugs Products Offered
11.3.5 Synedgen Inc Related Developments
11.4 Tonix Pharmaceuticals Holding Corp
11.4.1 Tonix Pharmaceuticals Holding Corp Corporation Information
11.4.2 Tonix Pharmaceuticals Holding Corp Description and Business Overview
11.4.3 Tonix Pharmaceuticals Holding Corp Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Tonix Pharmaceuticals Holding Corp Radiation Injury Drugs Products Offered
11.4.5 Tonix Pharmaceuticals Holding Corp Related Developments
11.5 Windtree Therapeutics Inc
11.5.1 Windtree Therapeutics Inc Corporation Information
11.5.2 Windtree Therapeutics Inc Description and Business Overview
11.5.3 Windtree Therapeutics Inc Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Windtree Therapeutics Inc Radiation Injury Drugs Products Offered
11.5.5 Windtree Therapeutics Inc Related Developments
11.1 FirstString Research Inc
11.1.1 FirstString Research Inc Corporation Information
11.1.2 FirstString Research Inc Description and Business Overview
11.1.3 FirstString Research Inc Sales, Revenue and Gross Margin (2015-2020)
11.1.4 FirstString Research Inc Radiation Injury Drugs Products Offered
11.1.5 FirstString Research Inc Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Radiation Injury Drugs Market Estimates and Projections by Region
12.1.1 Global Radiation Injury Drugs Sales Forecast by Regions 2021-2026
12.1.2 Global Radiation Injury Drugs Revenue Forecast by Regions 2021-2026
12.2 North America Radiation Injury Drugs Market Size Forecast (2021-2026)
12.2.1 North America: Radiation Injury Drugs Sales Forecast (2021-2026)
12.2.2 North America: Radiation Injury Drugs Revenue Forecast (2021-2026)
12.2.3 North America: Radiation Injury Drugs Market Size Forecast by Country (2021-2026)
12.3 Europe Radiation Injury Drugs Market Size Forecast (2021-2026)
12.3.1 Europe: Radiation Injury Drugs Sales Forecast (2021-2026)
12.3.2 Europe: Radiation Injury Drugs Revenue Forecast (2021-2026)
12.3.3 Europe: Radiation Injury Drugs Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Radiation Injury Drugs Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Radiation Injury Drugs Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Radiation Injury Drugs Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Radiation Injury Drugs Market Size Forecast by Region (2021-2026)
12.5 Latin America Radiation Injury Drugs Market Size Forecast (2021-2026)
12.5.1 Latin America: Radiation Injury Drugs Sales Forecast (2021-2026)
12.5.2 Latin America: Radiation Injury Drugs Revenue Forecast (2021-2026)
12.5.3 Latin America: Radiation Injury Drugs Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Radiation Injury Drugs Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Radiation Injury Drugs Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Radiation Injury Drugs Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Radiation Injury Drugs Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Radiation Injury Drugs Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Radiation Injury Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Radiation Injury Drugs Market Segments
Table 2. Ranking of Global Top Radiation Injury Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Radiation Injury Drugs Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of Aerosurf
Table 5. Major Manufacturers of BMX-001
Table 6. Major Manufacturers of C-2E2
Table 7. Major Manufacturers of C-2E5
Table 8. Major Manufacturers of Des-Asp Angiotensin 1
Table 9. Major Manufacturers of DG-3
Table 10. Major Manufacturers of Others
Table 11. Global Radiation Injury Drugs Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 12. Global Radiation Injury Drugs Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 13. Global Radiation Injury Drugs Sales by Regions 2015-2020 (K Pcs)
Table 14. Global Radiation Injury Drugs Sales Market Share by Regions (2015-2020)
Table 15. Global Radiation Injury Drugs Revenue by Regions 2015-2020 (US$ Million)
Table 16. Global Radiation Injury Drugs Sales by Manufacturers (2015-2020) (K Pcs)
Table 17. Global Radiation Injury Drugs Sales Share by Manufacturers (2015-2020)
Table 18. Global Radiation Injury Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 19. Global Radiation Injury Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Radiation Injury Drugs as of 2019)
Table 20. Radiation Injury Drugs Revenue by Manufacturers (2015-2020) (US$ Million)
Table 21. Radiation Injury Drugs Revenue Share by Manufacturers (2015-2020)
Table 22. Key Manufacturers Radiation Injury Drugs Price (2015-2020) (USD/Pcs)
Table 23. Radiation Injury Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Radiation Injury Drugs Product Type
Table 25. Date of International Manufacturers Enter into Radiation Injury Drugs Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Radiation Injury Drugs Sales by Type (2015-2020) (K Pcs)
Table 28. Global Radiation Injury Drugs Sales Share by Type (2015-2020)
Table 29. Global Radiation Injury Drugs Revenue by Type (2015-2020) (US$ Million)
Table 30. Global Radiation Injury Drugs Revenue Share by Type (2015-2020)
Table 31. Radiation Injury Drugs Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 32. Global Radiation Injury Drugs Sales by Application (2015-2020) (K Pcs)
Table 33. Global Radiation Injury Drugs Sales Share by Application (2015-2020)
Table 34. North America Radiation Injury Drugs Sales by Country (2015-2020) (K Pcs)
Table 35. North America Radiation Injury Drugs Sales Market Share by Country (2015-2020)
Table 36. North America Radiation Injury Drugs Revenue by Country (2015-2020) (US$ Million)
Table 37. North America Radiation Injury Drugs Revenue Market Share by Country (2015-2020)
Table 38. North America Radiation Injury Drugs Sales by Type (2015-2020) (K Pcs)
Table 39. North America Radiation Injury Drugs Sales Market Share by Type (2015-2020)
Table 40. North America Radiation Injury Drugs Sales by Application (2015-2020) (K Pcs)
Table 41. North America Radiation Injury Drugs Sales Market Share by Application (2015-2020)
Table 42. Europe Radiation Injury Drugs Sales by Country (2015-2020) (K Pcs)
Table 43. Europe Radiation Injury Drugs Sales Market Share by Country (2015-2020)
Table 44. Europe Radiation Injury Drugs Revenue by Country (2015-2020) (US$ Million)
Table 45. Europe Radiation Injury Drugs Revenue Market Share by Country (2015-2020)
Table 46. Europe Radiation Injury Drugs Sales by Type (2015-2020) (K Pcs)
Table 47. Europe Radiation Injury Drugs Sales Market Share by Type (2015-2020)
Table 48. Europe Radiation Injury Drugs Sales by Application (2015-2020) (K Pcs)
Table 49. Europe Radiation Injury Drugs Sales Market Share by Application (2015-2020)
Table 50. Asia Pacific Radiation Injury Drugs Sales by Region (2015-2020) (K Pcs)
Table 51. Asia Pacific Radiation Injury Drugs Sales Market Share by Region (2015-2020)
Table 52. Asia Pacific Radiation Injury Drugs Revenue by Region (2015-2020) (US$ Million)
Table 53. Asia Pacific Radiation Injury Drugs Revenue Market Share by Region (2015-2020)
Table 54. Asia Pacific Radiation Injury Drugs Sales by Type (2015-2020) (K Pcs)
Table 55. Asia Pacific Radiation Injury Drugs Sales Market Share by Type (2015-2020)
Table 56. Asia Pacific Radiation Injury Drugs Sales by Application (2015-2020) (K Pcs)
Table 57. Asia Pacific Radiation Injury Drugs Sales Market Share by Application (2015-2020)
Table 58. Latin America Radiation Injury Drugs Sales by Country (2015-2020) (K Pcs)
Table 59. Latin America Radiation Injury Drugs Sales Market Share by Country (2015-2020)
Table 60. Latin Americaa Radiation Injury Drugs Revenue by Country (2015-2020) (US$ Million)
Table 61. Latin America Radiation Injury Drugs Revenue Market Share by Country (2015-2020)
Table 62. Latin America Radiation Injury Drugs Sales by Type (2015-2020) (K Pcs)
Table 63. Latin America Radiation Injury Drugs Sales Market Share by Type (2015-2020)
Table 64. Latin America Radiation Injury Drugs Sales by Application (2015-2020) (K Pcs)
Table 65. Latin America Radiation Injury Drugs Sales Market Share by Application (2015-2020)
Table 66. Middle East and Africa Radiation Injury Drugs Sales by Country (2015-2020) (K Pcs)
Table 67. Middle East and Africa Radiation Injury Drugs Sales Market Share by Country (2015-2020)
Table 68. Middle East and Africa Radiation Injury Drugs Revenue by Country (2015-2020) (US$ Million)
Table 69. Middle East and Africa Radiation Injury Drugs Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa Radiation Injury Drugs Sales by Type (2015-2020) (K Pcs)
Table 71. Middle East and Africa Radiation Injury Drugs Sales Market Share by Type (2015-2020)
Table 72. Middle East and Africa Radiation Injury Drugs Sales by Application (2015-2020) (K Pcs)
Table 73. Middle East and Africa Radiation Injury Drugs Sales Market Share by Application (2015-2020)
Table 74. FirstString Research Inc Corporation Information
Table 75. FirstString Research Inc Description and Major Businesses
Table 76. FirstString Research Inc Radiation Injury Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 77. FirstString Research Inc Product
Table 78. FirstString Research Inc Recent Development
Table 79. PharmaIN Corp Corporation Information
Table 80. PharmaIN Corp Description and Major Businesses
Table 81. PharmaIN Corp Radiation Injury Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 82. PharmaIN Corp Product
Table 83. PharmaIN Corp Recent Development
Table 84. Synedgen Inc Corporation Information
Table 85. Synedgen Inc Description and Major Businesses
Table 86. Synedgen Inc Radiation Injury Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 87. Synedgen Inc Product
Table 88. Synedgen Inc Recent Development
Table 89. Tonix Pharmaceuticals Holding Corp Corporation Information
Table 90. Tonix Pharmaceuticals Holding Corp Description and Major Businesses
Table 91. Tonix Pharmaceuticals Holding Corp Radiation Injury Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 92. Tonix Pharmaceuticals Holding Corp Product
Table 93. Tonix Pharmaceuticals Holding Corp Recent Development
Table 94. Windtree Therapeutics Inc Corporation Information
Table 95. Windtree Therapeutics Inc Description and Major Businesses
Table 96. Windtree Therapeutics Inc Radiation Injury Drugs Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 97. Windtree Therapeutics Inc Product
Table 98. Windtree Therapeutics Inc Recent Development
Table 99. Global Radiation Injury Drugs Sales Forecast by Regions (2021-2026) (K Pcs)
Table 100. Global Radiation Injury Drugs Sales Market Share Forecast by Regions (2021-2026)
Table 101. Global Radiation Injury Drugs Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 102. Global Radiation Injury Drugs Revenue Market Share Forecast by Regions (2021-2026)
Table 103. North America: Radiation Injury Drugs Sales Forecast by Country (2021-2026) (K Pcs)
Table 104. North America: Radiation Injury Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 105. Europe: Radiation Injury Drugs Sales Forecast by Country (2021-2026) (K Pcs)
Table 106. Europe: Radiation Injury Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 107. Asia Pacific: Radiation Injury Drugs Sales Forecast by Region (2021-2026) (K Pcs)
Table 108. Asia Pacific: Radiation Injury Drugs Revenue Forecast by Region (2021-2026) (US$ Million)
Table 109. Latin America: Radiation Injury Drugs Sales Forecast by Country (2021-2026) (K Pcs)
Table 110. Latin America: Radiation Injury Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 111. Middle East and Africa: Radiation Injury Drugs Sales Forecast by Country (2021-2026) (K Pcs)
Table 112. Middle East and Africa: Radiation Injury Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 113. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 114. Key Challenges
Table 115. Market Risks
Table 116. Main Points Interviewed from Key Radiation Injury Drugs Players
Table 117. Radiation Injury Drugs Customers List
Table 118. Radiation Injury Drugs Distributors List
Table 119. Research Programs/Design for This Report
Table 120. Key Data Information from Secondary Sources
Table 121. Key Data Information from Primary Sources
List of Figures
Figure 1. Radiation Injury Drugs Product Picture
Figure 2. Global Radiation Injury Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Aerosurf Product Picture
Figure 4. BMX-001 Product Picture
Figure 5. C-2E2 Product Picture
Figure 6. C-2E5 Product Picture
Figure 7. Des-Asp Angiotensin 1 Product Picture
Figure 8. DG-3 Product Picture
Figure 9. Others Product Picture
Figure 10. Global Radiation Injury Drugs Sales Market Share by Application in 2020 & 2026
Figure 11. ASCs
Figure 12. Hospital
Figure 13. Clinic
Figure 14. Others
Figure 15. Radiation Injury Drugs Report Years Considered
Figure 16. Global Radiation Injury Drugs Market Size 2015-2026 (US$ Million)
Figure 17. Global Radiation Injury Drugs Sales 2015-2026 (K Pcs)
Figure 18. Global Radiation Injury Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 19. Global Radiation Injury Drugs Sales Market Share by Region (2015-2020)
Figure 20. Global Radiation Injury Drugs Sales Market Share by Region in 2019
Figure 21. Global Radiation Injury Drugs Revenue Market Share by Region (2015-2020)
Figure 22. Global Radiation Injury Drugs Revenue Market Share by Region in 2019
Figure 23. Global Radiation Injury Drugs Sales Share by Manufacturer in 2019
Figure 24. The Top 10 and 5 Players Market Share by Radiation Injury Drugs Revenue in 2019
Figure 25. Radiation Injury Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 26. Global Radiation Injury Drugs Sales Market Share by Type (2015-2020)
Figure 27. Global Radiation Injury Drugs Sales Market Share by Type in 2019
Figure 28. Global Radiation Injury Drugs Revenue Market Share by Type (2015-2020)
Figure 29. Global Radiation Injury Drugs Revenue Market Share by Type in 2019
Figure 30. Global Radiation Injury Drugs Market Share by Price Range (2015-2020)
Figure 31. Global Radiation Injury Drugs Sales Market Share by Application (2015-2020)
Figure 32. Global Radiation Injury Drugs Sales Market Share by Application in 2019
Figure 33. Global Radiation Injury Drugs Revenue Market Share by Application (2015-2020)
Figure 34. Global Radiation Injury Drugs Revenue Market Share by Application in 2019
Figure 35. North America Radiation Injury Drugs Sales Growth Rate 2015-2020 (K Pcs)
Figure 36. North America Radiation Injury Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 37. North America Radiation Injury Drugs Sales Market Share by Country in 2019
Figure 38. North America Radiation Injury Drugs Revenue Market Share by Country in 2019
Figure 39. U.S. Radiation Injury Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 40. U.S. Radiation Injury Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 41. Canada Radiation Injury Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 42. Canada Radiation Injury Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 43. North America Radiation Injury Drugs Market Share by Type in 2019
Figure 44. North America Radiation Injury Drugs Market Share by Application in 2019
Figure 45. Europe Radiation Injury Drugs Sales Growth Rate 2015-2020 (K Pcs)
Figure 46. Europe Radiation Injury Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 47. Europe Radiation Injury Drugs Sales Market Share by Country in 2019
Figure 48. Europe Radiation Injury Drugs Revenue Market Share by Country in 2019
Figure 49. Germany Radiation Injury Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 50. Germany Radiation Injury Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. France Radiation Injury Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 52. France Radiation Injury Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. U.K. Radiation Injury Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 54. U.K. Radiation Injury Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Italy Radiation Injury Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 56. Italy Radiation Injury Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Russia Radiation Injury Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 58. Russia Radiation Injury Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Europe Radiation Injury Drugs Market Share by Type in 2019
Figure 60. Europe Radiation Injury Drugs Market Share by Application in 2019
Figure 61. Asia Pacific Radiation Injury Drugs Sales Growth Rate 2015-2020 (K Pcs)
Figure 62. Asia Pacific Radiation Injury Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 63. Asia Pacific Radiation Injury Drugs Sales Market Share by Region in 2019
Figure 64. Asia Pacific Radiation Injury Drugs Revenue Market Share by Region in 2019
Figure 65. China Radiation Injury Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 66. China Radiation Injury Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Japan Radiation Injury Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 68. Japan Radiation Injury Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. South Korea Radiation Injury Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 70. South Korea Radiation Injury Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. India Radiation Injury Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 72. India Radiation Injury Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Australia Radiation Injury Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 74. Australia Radiation Injury Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Taiwan Radiation Injury Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 76. Taiwan Radiation Injury Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Indonesia Radiation Injury Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 78. Indonesia Radiation Injury Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Thailand Radiation Injury Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 80. Thailand Radiation Injury Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Malaysia Radiation Injury Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 82. Malaysia Radiation Injury Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Philippines Radiation Injury Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 84. Philippines Radiation Injury Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 85. Vietnam Radiation Injury Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 86. Vietnam Radiation Injury Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 87. Asia Pacific Radiation Injury Drugs Market Share by Type in 2019
Figure 88. Asia Pacific Radiation Injury Drugs Market Share by Application in 2019
Figure 89. Latin America Radiation Injury Drugs Sales Growth Rate 2015-2020 (K Pcs)
Figure 90. Latin America Radiation Injury Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 91. Latin America Radiation Injury Drugs Sales Market Share by Country in 2019
Figure 92. Latin America Radiation Injury Drugs Revenue Market Share by Country in 2019
Figure 93. Mexico Radiation Injury Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 94. Mexico Radiation Injury Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Brazil Radiation Injury Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 96. Brazil Radiation Injury Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 97. Argentina Radiation Injury Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 98. Argentina Radiation Injury Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 99. Latin America Radiation Injury Drugs Market Share by Type in 2019
Figure 100. Latin America Radiation Injury Drugs Market Share by Application in 2019
Figure 101. Middle East and Africa Radiation Injury Drugs Sales Growth Rate 2015-2020 (K Pcs)
Figure 102. Middle East and Africa Radiation Injury Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 103. Middle East and Africa Radiation Injury Drugs Sales Market Share by Country in 2019
Figure 104. Middle East and Africa Radiation Injury Drugs Revenue Market Share by Country in 2019
Figure 105. Turkey Radiation Injury Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 106. Turkey Radiation Injury Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. Saudi Arabia Radiation Injury Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 108. Saudi Arabia Radiation Injury Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 109. U.A.E Radiation Injury Drugs Sales Growth Rate (2015-2020) (K Pcs)
Figure 110. U.A.E Radiation Injury Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 111. Middle East and Africa Radiation Injury Drugs Market Share by Type in 2019
Figure 112. Middle East and Africa Radiation Injury Drugs Market Share by Application in 2019
Figure 113. North America Radiation Injury Drugs Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 114. North America Radiation Injury Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Europe Radiation Injury Drugs Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 116. Europe Radiation Injury Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Asia Pacific Radiation Injury Drugs Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 118. Asia Pacific Radiation Injury Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Latin America Radiation Injury Drugs Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 120. Latin America Radiation Injury Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 121. Middle East and Africa Radiation Injury Drugs Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 122. Middle East and Africa Radiation Injury Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 123. Porter's Five Forces Analysis
Figure 124. Channels of Distribution
Figure 125. Distributors Profiles
Figure 126. Bottom-up and Top-down Approaches for This Report
Figure 127. Data Triangulation
Figure 128. Key Executives Interviewed
急性脊髄損傷の世界市場（～2026年） Acute spinal cord injury (SCI) is a clinical condition caused due to a painful injury that result in a contusion or bruise to a fractional or complete spinal cord resulting into permanent disability and/or death in adults and children. The treatment of acute spinal cord injury is dependent on few f…- 放射線治療の世界市場（～2026年） Market Analysis and Insights: Global Radiation Therapy Market The global Radiation Therapy market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Radiation Therapy Scope and Market Size Radiation Therapy market is segmented b…
- 放射線皮膚炎治療の世界市場（～2026年） The pathophysiology of a radiation skin reaction is a combination of radiation injury and the subsequent inflammatory response and can occur at both the entrance and exit site of the irradiation. The major factor driving the radiation dermatitis treatment market is the increasing prevalence of cance…
- 電離放射線滅菌法の世界市場（～2026年） Market Analysis and Insights: Global Ionizing Radiation Sterlization Market The global Ionizing Radiation Sterlization market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Ionizing Radiation Sterlization Scope and Market Si…
- 放射線腫瘍学の世界市場（～2026年） Market Analysis and Insights: Global Radiation Oncology Market The global Radiation Oncology market size is projected to reach US$ 5491.5 million by 2026, from US$ 5199.5 million in 2020, at a CAGR of 5.2%% during 2021-2026. Global Radiation Oncology Scope and Market Size Radiation Oncology market i…